Organization Profile

You just read:

GlycoVaxyn announces the initiation of a Phase I clinical trial in collaboration with Janssen for a vaccine against Extra-intestinal pathogenic Escherichia coli causing urinary tract infection

News provided by

GlycoVaxyn AG

Jul 01, 2014, 02:00 ET